# Pharmacokinetic Study to Investigate the Bioavailability and Tolerability of 3 Oral Formulations of Sodium Thiosulfate

> **NCT02624479** · PHASE1 · WITHDRAWN · sponsor: **Insel Gruppe AG, University Hospital Bern**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Sodium thiosulfate

## Key facts

- **NCT ID:** NCT02624479
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-12
- **Primary completion:** 2019-05
- **Final completion:** 2019-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Formulations could never be successfully produced
- **Last updated:** 2023-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02624479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02624479, "Pharmacokinetic Study to Investigate the Bioavailability and Tolerability of 3 Oral Formulations of Sodium Thiosulfate". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02624479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*